Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Assessing AST released in a cell culture model of liver toxicity using AlphaLISA
Technical Note

Assessing AST released in a cell culture model of liver toxicity using AlphaLISA

using-alphalisa512

The Assessment of the Potential Hepatotoxicity of New Drugs by In Vitro Models.

Liver toxicity is a significant concern during drug development, necessitating early measurement. Human hepatoma cell lines, such as HepG2 cells, are commonly employed for in vitro studies of liver function, metabolism, and drug toxicity.

In this technical note, we showcase the utility and advantages of using AlphaLISA assays to identify and quantify AST protein levels in cellular lysate and supernatant from a human hepatoma cell line.

For research use only. Not for use in diagnostic procedures.

Download Resource

Assessing AST released in a cell culture model of liver toxicity using AlphaLISA

Download Technical Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.